Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 9/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 9/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | SLC22A6 | Q4U2R8 | 3/20 | 0.61 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.61 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.61 |
| ▸ | THPO | P40225 | 1/20 | 0.61 |
| ▸ | AKR1C3 | P42330 | 6/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1651840 | 1.00 | PTGS1 (0.61) | PTGS1PTGS2MAPTSLC22A6CXCR1 | |
| SCHEMBL3240938 | 1.00 | PTGS1 (0.61) | PTGS1PTGS2MAPTSLC22A6CXCR1 | |
| SCHEMBL29948859 | 1.00 | PTGS1 (0.61) | PTGS1PTGS2MAPTSLC22A6CXCR1 | |
| SCHEMBL15695550 | 0.88 | AKR1C3 (0.49) | PTGS1PTGS2MAPTSLC22A6CXCR1 | |
| SCHEMBL20230822 | 0.88 | AKR1C3 (0.49) | PTGS1PTGS2MAPTSLC22A6CXCR1 | |
| SCHEMBL602096 | 0.87 | PTGS2 (0.69) | PTGS1PTGS2MAPTSLC22A6CXCR1 | |
| SCHEMBL10443244 | 0.85 | ACP3 (0.49) | PTGS1PTGS2MAPTSLC22A6CXCR1 | |
| SCHEMBL3053512 | 0.82 | PARP1 (0.50) | PTGS1PTGS2MAPTSLC22A6CXCR1 | |
| SCHEMBL2153144 | 0.82 | ACP3 (0.46) | PTGS1PTGS2MAPTSLC22A6CXCR1 | |
| SCHEMBL17147283 | 0.82 | ACP3 (0.50) | PTGS1PTGS2MAPTSLC22A6CXCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115872849-A | Method for preparing 2, 5-dimethylphenylacetic acid | 阜新睿光氟化学有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-110305010-B | Preparation method of 2, 5-dimethylphenylacetic acid | 江苏中旗科技股份有限公司 | 2022-05-13 | — | — | CN | claimed |
| WO-2025074305-A1 | N-(1-(AMINOMETHYL)CYCLOPROPYL)(ARYL OR HETEROARYL) CARBOXAMIDE DERIVATIVES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-04-10 | — | — | WO | disclosed |
| CN-118666764-A | Triazole amide compound, preparation method and application thereof | 中国人民解放军海军军医大学 | 2024-09-20 | — | — | CN | disclosed |
| WO-2024010529-A1 | PRODUCTION OF ENANTIOPURE ALCOHOLS, AMINES AND ACIDS FROM RACEMIC EPOXIDES BY CASCADE BIOTRANSFORMATION INVOLVING EPOXIDE ISOMERIZATION AND DYNAMIC KINETIC RESOLUTION | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2024-01-11 | — | — | WO | disclosed |
| US-20230111101-A1 | PROCESS FOR THE PREPARATION OF A CHIRAL PROSTAGLANDIN ENOL INTERMEDIATE AND INTERMEDIATE COMPOUNDS USEFUL IN THE PROCESS | EUROAPI HUNGARY LIMITED LIABILITY COMPANY (HU) | 2023-04-13 | — | — | US | disclosed |
| CN-115872849-A | Method for preparing 2, 5-dimethylphenylacetic acid | 阜新睿光氟化学有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-115872849-A | Method for preparing 2, 5-dimethylphenylacetic acid | 阜新睿光氟化学有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-115485270-A | Process for preparing chiral prostaglandin enol intermediates and intermediate compounds useful in the process | 欧宜平匈牙利有限责任公司 | 2022-12-16 | — | — | CN | disclosed |
| EP-4100385-A1 | REARRANGEMENT OF DIMETHYLPHENYLACYLATES USING ZEOLITES | DSM IP Assets B.V. (NL) | 2022-12-14 | — | — | EP | disclosed |
| EP-4077298-A1 | PROCESS FOR THE PREPARATION OF A CHIRAL PROSTAGLANDIN ENOL INTERMEDIATE AND INTERMEDIATE COMPOUNDS USEFUL IN THE PROCESS | EUROAPI Hungary Limited Liability Company (HU) | 2022-10-26 | — | — | EP | disclosed |
| EP-1550662-A1 | NOVEL ADENINE COMPOUND AND USE THEREOF | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2005-07-06 | — | — | EP | disclosed |
| WO-2005005393-A2 | CCK-1 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-01-20 | — | — | WO | disclosed |
| US-6479693-B2 | REACTING AN ETHENICALLY UNSATURATED COMPOUND SUCH AS STYRENE WITH AN ALCOHOL AND CARBON MONOXIDE IN ORGANIC SOLVENT USING WATER SOLUBLE PALLADIUM COMPLEX CATALYST TO OBTAIN SATURATED ALKOXYCARBONYLATED COMPOUND | COUNCIL OF SCIENTIFIC AND INDUSTIAL RESEARCH (IN) | 2002-11-12 | — | — | US | disclosed |
| US-20020137964-A1 | Process for the preparation of a saturated carboxylic acid ester | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH | 2002-09-26 | — | — | US | disclosed |
| EP-0386243-A1 | PLATINUM (II) COMPLEXES | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1990-09-12 | — | — | EP | disclosed |
| US-4465855-A | ANTIREUMATIC & ANTIINFLAMMATORIES | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT (HU) | 1984-08-14 | — | — | US | disclosed |
| US-4385004-A | Esters of ortho-allylphenol useful for the preparation of arylacetic acid derivatives | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1983-05-24 | — | — | US | disclosed |
| US-4317920-A | ANTIRHEUMATIC AGENTS, ANTIINFLAMMATORY AGENTS | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1982-03-02 | — | — | US | disclosed |
| US-RE29981-E | FROM FORMIC ESTERS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1979-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230111101-A1 | PROCESS FOR THE PREPARATION OF A CHIRAL PROSTAGLANDIN ENOL INTERMEDIATE AND INTERMEDIATE COMPOUNDS USEFUL IN THE PROCESS | PTGER1, PTGER4, PTGER2 | PTGS1 9/4885PTGS2 19/4885MAPT 4689/4885 |
| US-20020137964-A1 | Process for the preparation of a saturated carboxylic acid ester | ADH1C, ADH1A, ADH5 | PTGS1 894/4885PTGS2 760/4885MAPT 3582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.